12:10 – 12:30 pm Friday, October 29

Paper Presentation: Supportive Care/Quality Improvement — Beyond Words: Expressing Hope Through Creative Art Among Adolescents Who Have Advanced Cancer (216-3)

Purpose/Objectives: This study aimed to (1) conceptualize the essence of hope among adolescents with advanced cancer based on their lived experiences and (2) illustrate how hope evolves through participants’ verbal and artistic depictions of their lived experiences with hope. Four of these drawings and verbatim descriptions are presented as a case series.

Read more...
11:30 am – 12:30 pm Saturday, October 30

Paper Presentation: Program Development — Building a Sustainable and Structured Continuing Education Program for Pediatric Oncology Nurses in Vietnam (228-3)

There is a lack of continuing education opportunities for oncology nurses at the 13 pediatric cancer treatment centers in Vietnam. This presentation will discuss how nurses from the United States, Singapore, and Vietnam collaborated to develop an in-country, web-based educational program utilizing a variety of virtual teaching strategies.

Read more...
11:30 am – 12:30 pm Saturday, October 30

Paper Presentation: Program Development — When Two Become One: Joining Two Programs to Promote Family-Centered Care for Pediatric Patients Undergoing Bone Marrow Transplantation (228-2)

Transplants often require families to be away from family and support networks for long periods of time. Patients are often acutely ill and require specialized care. Because of the complexity of treatment and the potential for complications, transplant is stressful and challenging for patients and their caregivers. To cope with this stress, many families rely on supportive systems, including family and friends.

Read more...
11:30 am – 12:30 pm Saturday, October 30

Paper Presentation: Program Development — Nursing Practice Advocate: An Innovative Role Created to Reduce Harm While Supporting and Engaging Bedside Nursing Staff (228-1)

In 2019, inpatient pediatric hematology/oncology (PHO) and stem cell transplant (SCT) units within a children’s hospital experienced an increase in central line–associated bloodstream infections (CLABSIs) and mucosal barrier injury laboratory-confirmed bloodstream infections (MBI-LCBIs).

Read more...
3:30 – 4:30 pm Friday, October 29

Paper Presentation: Long Term (or Chronic) Supportive Care — Long-term Anticoagulation in Children Utilizing Fondaparinux-A Single Pediatric Center Experience (222-3)

Fondaparinux is a synthetic, subcutaneously administered heparinoid that selectively inhibits activated factor X. Pediatric studies of fondaparinux have shown safety and efficacy profiles for the treatment of venous thromboembolism that was similar to standard pediatric anticoagulants.

Read more...
3:30 – 4:30 pm Friday, October 29

Paper Presentation: Long Term (or Chronic) Supportive Care — Individualized Pain Plans in Managing Pain in Patients with Sickle Cell Disease (222-2)

Vaso-occlusive crisis (VOC) is the leading cause of hospital admissions in pediatric patients with sickle cell disease (SCD). Achieving the maximum opioid dose earlier in the admission is associated with shorter lengths of stays, allowing children suffering from SCD to spend less time in the hospital and decreasing their risk for depression and other long-term hospital-associated complications.

Read more...
11:50 am – 12:10 pm Friday, October 29

Paper Presentation: Supportive Care/Quality Improvement — Findings from an International Delphi-Study to Develop a Preliminary Core Set of Nursing-Sensitive Quality Indicators for Pediatric Oncology (216-2)

Although nursing-sensitive indicators (NSIs) have been developed to measure factors influencing nursing care quality and patient outcomes in general and in select specialty areas, a core set of NSIs for international pediatric oncology nursing practice does not exist.

Read more...
11:30 am – 12:30 pm Friday, October 29

Paper Presentation: Supportive Care/Quality Improvement — Changes in CLABSI Rates Following Implementation of Antibacterial Prophylaxis for Children and Adolescents with High-Risk Hematologic Malignancies (216-1)

Children and adolescents with hematologic malignancies remain at heightened risk for central line–associated bloodstream infection (CLABSI), including CLABSIs involving organisms common to the lower gastrointestinal tract, which have been least responsive to interventions. This project evaluated changes in CLABSI rates following implementation of antibacterial prophylaxis for patients with high-risk hematologic malignancies. Read more...
Speaker:
Lauri A. Linder, PhD APRN CPON®
CNE Hours
1
5:00 – 6:00 pm Thursday, October 28

Paper Presentation: Child/Adolescent Cancer Treatment Experience — Do CSF Biomarkers Relate to Measures of Cognitive Function in Children During Maintenance Therapy for Leukemia? (210-3)

Children treated for acute lymphocytic leukemia (ALL) receive central nervous system–directed chemotherapy, which is a known risk factor for cognitive dysfunction. ALL chemotherapy treatment is also associated with changes in biomarkers of inflammation and oxidative stress, which may underlie changes in neurocognitive functioning.

Read more...
Subscribe to this RSS feed